Bio-Path Holdings Gross Profit 2009-2019 | BPTH

Bio-Path Holdings gross profit from 2009 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Bio-Path Holdings Annual Gross Profit
(Millions of US $)
2018 $
2017 $0
2016 $0
2015 $
2014 $
2013 $
2012 $
2011 $
2010 $
2009 $
2008 $
2007 $
Bio-Path Holdings Quarterly Gross Profit
(Millions of US $)
Q2 2019
Q1 2019
Q4 2018
Q3 2018
Q2 2018
Q1 2018
Q4 2017
Q3 2017
Q2 2017
Q1 2017
Q4 2016
Q3 2016
Q2 2016
Q1 2016
Q4 2015
Q3 2015
Q2 2015
Q1 2015
Q4 2014
Q3 2014
Q2 2014
Q1 2014
Q4 2013
Q3 2013
Q2 2013
Q1 2013
Q4 2012
Q3 2012
Q2 2012
Q1 2012
Q4 2011
Q3 2011
Q2 2011
Q1 2011
Q4 2010
Q3 2010
Q2 2010
Q1 2010
Q4 2009
Q3 2009
Q2 2009
Q1 2009
Q4 2008
Q3 2008
Q2 2008
Q1 2008
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.031B $0.000B
BIO-PATH is developing leading-edge, patented, liposomal drug delivery systems, with two clinical cancer drug candidates ready for the clinic and a third siRNA cancer drug undergoing final pre-clinical development. Bio-Path's drug delivery technology distributes nucleic acid drugs systemically, throughout the human body, via simple intravenous infusion. The delivery technology can be applied both to double stranded and single stranded nucleic acid compounds with the potential to revolutionize the treatment of cancer and other diseases where drugable targets of disease are well characterized.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $60.454B 37.23
Takeda Pharmaceutical (TAK) Japan $53.771B 8.41
Astellas Pharma (ALPMY) Japan $29.086B 13.86
Merck (MKGAF) Germany $14.682B 20.03
Eisai (ESALY) Japan $14.552B 22.28
Grifols, S.A (GRFS) Spain $14.047B 17.92
UCB SA (UCBJF) Belgium $13.839B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.212B 19.69
Ionis Pharmaceuticals (IONS) United States $8.785B 18.95
Neurocrine Biosciences (NBIX) United States $8.326B 0.00
IPSEN SA ADR (IPSEY) France $7.776B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $7.257B 0.00
Sage Therapeutics (SAGE) United States $7.197B 0.00
Catalent (CTLT) United States $7.070B 27.94
Jazz Pharmaceuticals (JAZZ) Ireland $6.661B 8.77
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.118B 0.00
STADA ARZNEIMI (STDAF) Germany $5.547B 0.00
Orion OYJ (ORINY) Finland $5.275B 27.16
Hypermarcas (HYPMY) Brazil $5.172B 18.59
United Therapeutics (UTHR) United States $3.563B 0.00
FibroGen (FGEN) United States $3.305B 82.67
Evotec AG (EVTCY) Germany $3.277B 44.87
Arrowhead Pharmaceuticals (ARWR) United States $3.127B 71.70
Taro Pharmaceutical Industries (TARO) Israel $2.863B 10.26
Nektar Therapeutics (NKTR) United States $2.782B 0.00
PTC Therapeutics (PTCT) United States $2.175B 0.00
Tilray (TLRY) Canada $2.017B 0.00
Xencor (XNCR) United States $1.925B 41.97
Portola Pharmaceuticals (PTLA) United States $1.835B 0.00
Zogenix (ZGNX) United States $1.835B 0.00
Corcept Therapeutics (CORT) United States $1.597B 21.95
USANA Health Sciences (USNA) United States $1.529B 15.33
Pacira Pharmaceuticals (PCRX) United States $1.524B 55.47
Heron Therapeutics (HRTX) United States $1.413B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.362B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.308B 0.00
Radius Health (RDUS) United States $1.155B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.147B 18.92
ArQule (ARQL) United States $1.017B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.974B 0.00
TherapeuticsMD (TXMD) United States $0.948B 0.00
Aerie Pharmaceuticals (AERI) United States $0.905B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.837B 0.00
Dova Pharmaceuticals (DOVA) United States $0.810B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.808B 3.60
Endo (ENDP) Ireland $0.761B 1.34
Organogenesis Holdings (ORGO) United States $0.719B 0.00
Concordia (CXRXF) Canada $0.633B 0.00
Karyopharm Therapeutics (KPTI) United States $0.626B 0.00
Flexion Therapeutics (FLXN) United States $0.526B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.510B 0.00
Akebia Therapeutics (AKBA) United States $0.493B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.458B 0.00
Siga Technologies (SIGA) United States $0.440B 1.03
Lannett Co Inc (LCI) United States $0.437B 4.60
Indivior (INVVY) United States $0.437B 1.58
ChemoCentryx (CCXI) United States $0.422B 0.00
Translate Bio (TBIO) United States $0.409B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.402B 0.00
Collegium Pharmaceutical (COLL) United States $0.394B 0.00
Innate Pharma SA (IPHYF) France $0.392B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.366B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.365B 16.61
ImmunoGen (IMGN) United States $0.346B 0.00
DURECT (DRRX) United States $0.346B 0.00
Rafael Holdings (RFL) United States $0.320B 0.00
Harpoon Therapeutics (HARP) United States $0.319B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.301B 0.00
Dermira (DERM) United States $0.289B 0.00
OptiNose (OPTN) United States $0.282B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.278B 0.00
Ardelyx (ARDX) United States $0.276B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.264B 0.00
Recro Pharma (REPH) United States $0.248B 0.00
Molecular Templates (MTEM) United States $0.247B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.231B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.209B 0.00
Xeris Pharmaceuticals (XERS) United States $0.208B 0.00
GlycoMimetics (GLYC) United States $0.193B 0.00
KalVista Pharmaceuticals (KALV) United States $0.191B 0.00
CV Sciences (CVSI) United States $0.185B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.174B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.173B 0.00
Nature's Sunshine Products (NATR) United States $0.171B 28.55
Taiwan Liposome (TLC) Taiwan $0.169B 0.00
CannTrust Holdings (CTST) Canada $0.147B 0.00
Ocular Therapeutix (OCUL) United States $0.144B 0.00
IMV INC (IMV) Canada $0.141B 0.00
Concert Pharmaceuticals (CNCE) United States $0.140B 0.00
Redhill Biopharma (RDHL) Israel $0.138B 0.00
Calithera Biosciences (CALA) United States $0.137B 0.00
Generex Biotechnology (GNBT) United States $0.131B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.131B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.125B 0.00
MEI Pharma (MEIP) United States $0.118B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.111B 0.00
Jounce Therapeutics (JNCE) United States $0.109B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.088B 33.71
Cardiome Pharma (CORV) Canada $0.086B 0.00
MediWound (MDWD) Israel $0.082B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.080B 0.00
Aquestive Therapeutics (AQST) United States $0.080B 0.00
Majesco Entertainment (PTE) United States $0.076B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.076B 0.00
Lipocine (LPCN) United States $0.071B 0.00
Otonomy (OTIC) United States $0.069B 0.00
AgeX Therapeutics (AGE) United States $0.068B 0.00
Genocea Biosciences (GNCA) United States $0.068B 0.00
Neos Therapeutics (NEOS) United States $0.068B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.068B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
RENEURON GP (RNUGF) United Kingdom $0.065B 0.00
Novan (NOVN) United States $0.064B 0.00
Natural Alternatives (NAII) United States $0.062B 9.35
IntelGenx Technologies (IGXT) Canada $0.061B 0.00
SCYNEXIS (SCYX) United States $0.058B 0.00
Aclaris Therapeutics (ACRS) United States $0.058B 0.00
ElectroCore (ECOR) United States $0.058B 0.00
Infinity Pharmaceuticals (INFI) United States $0.058B 0.00
Nivalis Therapeutics (ALPN) United States $0.056B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.055B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
Iterum Therapeutics (ITRM) Ireland $0.054B 0.00
Melinta Therapeutics (MLNT) United States $0.054B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.052B 0.00
Capnia (SLNO) United States $0.050B 0.00
Forward Pharma (FWP) Denmark $0.044B 0.00
CTI BioPharma (CTIC) United States $0.044B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.038B 0.00
Mast Therapeutics (SVRA) United States $0.036B 0.00
India Globalization Capital (IGC) United States $0.034B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.032B 0.00
Jaguar Animal Health (JAGX) United States $0.032B 0.00
PharmAthene (ALT) United States $0.030B 0.00
Biomerica (BMRA) United States $0.030B 0.00
Opexa Therapeutics (ACER) United States $0.029B 0.00
China SXT Pharmaceuticals (SXTC) China $0.027B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
IsoRay (ISR) United States $0.021B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Vical (BBI) United States $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Heat Biologics (HTBX) United States $0.013B 0.00
Achieve Life Sciences (ACHV) United States $0.012B 0.00
Shineco (TYHT) China $0.012B 17.29
Eyegate Pharmaceuticals (EYEG) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.011B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
RXi Pharmaceuticals (PHIO) United States $0.005B 0.00
Onconova Therapeutics (ONTX) United States $0.005B 0.00
Midatech Pharma (MTP) United Kingdom $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Hemispherx BioPharma (AIM) United States $0.002B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00